Skip to main content
Neogen Chemicals Limited logo

Neogen Chemicals Limited — Investor Relations & Filings

Ticker · NEOGEN ISIN · INE136S01016 LEI · 335800PFY9B77Z2GOK22 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2025-04-01 Major Shareholding Noti…
Country IN India
Listing BSE.NS NEOGEN

About Neogen Chemicals Limited

https://neogenchem.com/

Neogen Chemicals Limited specializes in the development and large-scale manufacturing of bromine-based and lithium-based specialty chemicals. The product portfolio includes a diverse range of bromine derivatives, lithium salts, Grignard reagents, and advanced intermediates. These products serve critical roles in pharmaceutical, agrochemical, and engineering applications. The company has expanded its operations into the energy storage market, focusing on the production of electrolytes and lithium salts for lithium-ion batteries. With a strong emphasis on research and development, the firm provides custom synthesis and contract manufacturing services to global innovators. Manufacturing capabilities are supported by multi-product facilities designed to meet stringent quality standards for complex chemical processes and high-purity requirements.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is a detailed disclosure under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It pertains to a proposed acquisition of shares by way of gift (an inter-se transfer among promoters) and includes detailed shareholding information before and after the transaction, declarations of compliance with takeover regulations, and other regulatory disclosures. The document is addressed to stock exchanges and is a formal notification of a substantial acquisition of shares. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document is not an annual report, earnings release, or any other report type but a regulatory disclosure about shareholding changes.
2025-04-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification from the company to stock exchanges about the closure of the trading window in compliance with insider trading regulations. It mentions the upcoming declaration of audited financial results for the quarter and financial year ended March 31, 2025, but does not contain any financial data or the results themselves. The document is short (2270 characters) and serves as an announcement related to regulatory compliance and trading restrictions rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and announcement documents that do not contain substantive financial data or detailed report content.
2025-03-31 English
General Updates
Major Shareholding Notification Classification · 95% confidence The document is an official disclosure submitted to stock exchanges regarding an inter-se transfer of shares among promoters of Neogen Chemicals Limited. It references specific regulations under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, particularly Regulation 10(5) and exemptions under Regulation 10(1)(a). The content includes detailed information about the share transfer, the parties involved, and compliance declarations. This type of document is a regulatory disclosure about changes in substantial shareholding or promoter share transfers, not a financial report, earnings release, or management discussion. It fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels, including inter-se transfers among promoters that affect shareholding disclosures.
2025-03-29 English
Agreements
Capital/Financing Update Classification · 95% confidence The document is a formal communication from Neogen Chemicals Limited to stock exchanges regarding the outcome of a Board Meeting held on March 25, 2025. The key content is the approval of an investment in a wholly owned subsidiary, Neogen Chemicals Japan Corporation Limited, by subscribing to equity shares. The document includes detailed disclosures pursuant to SEBI Listing Regulations and related circulars, including annexures with specifics of the investment and the share subscription agreement. There are no financial statements, quarterly or annual results, or management discussion and analysis. The document is an announcement of a corporate action (investment and share subscription) approved by the Board, fulfilling regulatory disclosure requirements. It is not a full financial report, earnings release, or management report. It is also not a proxy, voting result, or remuneration report. The document fits best under Capital/Financing Update (CAP) as it relates to the company's capital investment and share subscription in a subsidiary, which is a financing activity disclosed to the market.
2025-03-25 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is a formal communication from Neogen Chemicals Limited to stock exchanges regarding the outcome of a Board Meeting held on March 25, 2025. The key content is the approval of an investment in a wholly owned subsidiary, Neogen Chemicals Japan Corporation Limited, by subscribing to equity shares. The document includes detailed disclosures pursuant to SEBI Listing Regulations and SEBI circulars, including annexures with specifics of the investment and the share subscription agreement. There are no financial statements, quarterly or annual results, or audit opinions presented. The document is an announcement of a corporate action (investment and share subscription) approved by the Board, fulfilling regulatory disclosure requirements. It is not a full financial report, earnings release, or management discussion. The document fits the category of Capital/Financing Update (CAP) as it relates to the company's financing activity and capital structure changes through investment in a subsidiary.
2025-03-25 English
Outcome of Board Meeting
Capital/Financing Update Classification · 95% confidence The document is a formal communication from Neogen Chemicals Limited to stock exchanges regarding the outcome of a Board Meeting held on March 25, 2025. The key content is the approval of an investment in a wholly owned subsidiary, Neogen Chemicals Japan Corporation Limited, by subscribing to equity shares. The document includes detailed disclosures pursuant to SEBI Listing Regulations and related SEBI circulars, including annexures with specifics of the investment and the share subscription agreement. There are no financial statements, quarterly or annual results, or management discussion and analysis. The document is an announcement of a corporate action (investment and share subscription) approved by the Board, fulfilling regulatory disclosure requirements. It is not a full financial report, earnings release, or management report. It is also not a proxy, voting result, or remuneration report. The document fits best under Capital/Financing Update (CAP) as it relates to the company's financing activity and capital structure changes through investment in a subsidiary. The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive regulatory disclosure about capital investment.
2025-03-25 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.